Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer-Reference-Cited by-同舟云学术

Determining the Impact of Spatial Heterogeneity on Genomic Prognostic Biomarkers for Localized Prostate Cancer

Published:2020-06 Issue: Volume: Page:
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Brastianos Harry C.,Murgic Jure^ORCID,Salcedo Adriana,Chua Melvin L.K.,Meng Alice^ORCID,Fraser Michael^ORCID,Brundage Michael,Fleshner Neil E.,van der Kwast Theodorus,Bristow Robert G.,Boutros Paul C.,Berlin Alejandro^ORCID

Funder

Movember Foundation

Canadian Cancer Society

CIHR Project Grant

Terry Fox Research Institute New Investigator Award

CIHR New Investigator Award

Ontario Association of Radiation Oncologist Clinician Scientist Award

Princess Margaret Cancer Centre Foundation

Publisher

Elsevier BV

Subject

Urology,Radiology, Nuclear Medicine and imaging,Oncology,Surgery

Reference10 articles.

1. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

2. Validating the interval to biochemical failure for the identification of potentially lethal prostate cancer;Buyyounouski;J Clin Oncol,2012

3. Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study;Lalonde;Lancet Oncol,2014

4. Translating a prognostic DNA genomic classifier into the clinic: retrospective validation in 563 localized prostate tumors;Lalonde;Eur Urol,2017

5. Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy;Erho;PLoS One,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Synergistic Strategy Combining Chemotherapy and Photodynamic Therapy to Eradicate Prostate Cancer;International Journal of Molecular Sciences;2024-06-28

2. P‐score in preoperative biopsies accurately predicts P‐score in final pathology at radical prostatectomy in patients with localized prostate cancer;The Prostate;2023-03-20

3. Transcriptomic Features of Cribriform and Intraductal Carcinoma of the Prostate;European Urology Focus;2022-11

4. Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance;npj Precision Oncology;2022-05-04

5. Radiomics in prostate cancer: an up-to-date review;Therapeutic Advances in Urology;2022-01